Patents Assigned to DR.KADE Pharmazeutische Fabrik GmbH
  • Publication number: 20030109507
    Abstract: The present invention relates to semisolid transcutaneous medicaments based on at least one oxidation-sensitive progestin or a pharmaceutically acceptable derivative thereof. The medicaments comprise ascorbic acid, an ascorbic acid derivative or a salt thereof and have excellent stability. Corresponding gels which comprise a combination of norethisterone acetate and estradiol are described in particular.
    Type: Application
    Filed: September 20, 2002
    Publication date: June 12, 2003
    Applicant: DR.KADE Pharmazeutische Fabrik GmbH
    Inventors: Christian Franke, Karsten Beckmann